Back

Effects of guideline directed medical therapy on secondary mitral regurgitation

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Secondary valvular regurgitation: classification, prognosis and intervention Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Georg Spinka

Medical University of Vienna, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Supervised learning-derived tailored risk-stratification in patients with severe secondary mitral regurgitation
Doctor G. Heitzinger (Vienna, AT)
Abstract Slides
Presentation thumbnail
Impact of left ventricular contractility on mitral annular motion in an acute animal model
Doctor R. Persson (Bergen, NO)
Abstract Slides
Presentation thumbnail
A preliminary analysis regarding functional mitral regurgitation grading with echocardiography and CMR: in search of similarities and resolving discordances.
Doctor S. Maltes (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Influence of pacemaker leads on the severity of tricuspid regurgitation after successful mitral valve edge to edge repair
Mr M. Alsaad (Detmold, DE)
Abstract Slides
Presentation thumbnail
Utility and futility of MitraClip implantation in secondary mitral regurgitation in a real-world population: the role of 3D transthoracic echocardiography.
Doctor V. Mantegazza (Milano, IT)
Abstract Slides

Access the full session

Session thumbnail
Secondary valvular regurgitation: classification, prognosis and intervention

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources